Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
inverted papilloma
recurrence
squamous cell carcinoma
survival
systematic review
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
03
11
2021
received:
21
04
2021
accepted:
24
01
2022
pubmed:
11
2
2022
medline:
1
4
2022
entrez:
10
2
2022
Statut:
ppublish
Résumé
Long-term survival and recurrence patterns of squamous cell carcinoma arising from inverted papilloma (IP-SCC) have not been thoroughly investigated. Four electronic databases were searched and primary studies describing overall survival (OS), recurrence, and mean time to recurrence of patients with IP-SCC were included for review. Our search yielded 662 studies. The 28 studies selected for inclusion identified 663 patients with IP-SCC. In 596 patients with reported T classification, 439 (73.7%) were T3/T4 on presentation. Of the 650 participants with recurrence data (local, regional, and distant), 155 (23.8%) experienced a recurrence, with an aggregate mean time-to-recurrence of 24.3 months. In 565 patients with 5-year OS rates, the aggregate 5-year OS was 62%. Based on the literature to date, IP-SCC is associated with a 5-year OS rate of 62%. 23.8% of patients experienced recurrence at a mean time of 24.3 months, suggesting the need for long-term surveillance.
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1014-1029Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Suh JD, Ramakrishnan VR, Thompson CF, et al. Inverted papilloma of the sphenoid sinus: risk factors for disease recurrence. Laryngoscope. 2015;125(3):544-548.
Lawson W, Kaufman MR, Biller HF. Treatment outcomes in the management of inverted papilloma: an analysis of 160 cases. Laryngoscope. 2003;113(9):1548-1556.
Wang M-J, Noel JE. Etiology of sinonasal inverted papilloma: a narrative review. World J Otorhinolaryngol Head Neck Surg. 2017;3(1):54-58.
Goudakos JK, Blioskas S, Nikolaou A, Vlachtsis K, Karkos P, Markou KD. Endoscopic resection of sinonasal inverted papilloma: systematic review and meta-analysis. Am J Rhinol Allergy. 2018;32(3):167-174.
Peng P, Har-El G. Management of inverted papillomas of the nose and paranasal sinuses. Am J Otolaryngol. 2006;27(4):233-237.
Mirza S, Bradley PJ, Acharya A, Stacey M, Jones NS. Sinonasal inverted papillomas: recurrence, and synchronous and metachronous malignancy. J Laryngol Otol. 2007;121(9):857-864.
Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope. 1995;105(2):178-183.
Katori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol. 2005;31(8):905-911.
Gamrot-Wrzoł M, Sowa P, Lisowska G, Ścierski W, Misiołek M. Risk factors of recurrence and malignant transformation of sinonasal inverted papilloma. Biomed Res Int. 2017;2017:e9195163.
Moon IJ, Lee DY, Suh M-W, et al. Cigarette smoking increases risk of recurrence for sinonasal inverted papilloma. Am J Rhinol Allergy. 2010;24(5):325-329.
Hong S-L, Kim B-H, Lee J-H, Cho K-S, Roh H-J. Smoking and malignancy in sinonasal inverted papilloma. Laryngoscope. 2013;123(5):1087-1091.
d'Errico A, Zajacova J, Cacciatore A, et al. Occupational risk factors for sinonasal inverted papilloma: a case-control study. Occup Environ Med. 2013;70(10):703-708.
Lin GC, Scheel A, Akkina S, et al. Epidermal growth factor receptor, p16, cyclin D1, and p53 staining patterns for inverted papilloma. Int Forum Allergy Rhinol. 2013;3(11):885-889.
Lee G-H, Yoon Y-H, Kim YM, et al. Pattern of expression of cyclooxygenase-2 in malignant transformation of sinonasal inverted papilloma. Am J Otolaryngol. 2012;33(5):585-589.
Lin GC, Akkina S, Chinn S, et al. Sinonasal inverted papilloma: prognostic factors with emphasis on resection margins. J Neurol Surg B Skull Base. 2014;75(2):140-146.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712-716.
Oikawa K, Furuta Y, Itoh T, Oridate N, Fukuda S. Clinical and pathological analysis of recurrent inverted papilloma. Ann Otol Rhinol Laryngol. 2007;116(4):297-303.
Saldana M, Wearne M, Beigi B, Petrarca R. Inverted Papillomas of the nasal and paranasal sinuses that involve the ocular/adnexal region. Orbit. 2013;32(6):366-369.
Díaz Molina JP, Llorente Pendas JL, Rodrigo Tapia JP, Alvarez Marcos C, Obeso Agüera S, Suárez NC. Inverted sinonasal papillomas. Review of 61 cases. Acta Otorrinolaringol Esp. 2009;60(6):402-408.
Yu H-X, Liu G. Malignant transformation of sinonasal inverted papilloma: a retrospective analysis of 32 cases. Oncol Lett. 2014;8(6):2637-2641.
Choi JW, Kim SG, Kim Y-M, Yoon Y-H, Kim AY, Rha K-S. Clinical and histologic features of inverted papilloma-associated malignancy. Eur Arch Otorhinolaryngol. 2012;269(11):2349-2354.
Miyazaki T, Haku Y, Yoshizawa A, et al. Clinical features of nasal and sinonasal inverted papilloma associated with malignancy. Auris Nasus Larynx. 2018;45(5):1014-1019.
Woodworth BA, Bhargave GA, Palmer JN, et al. Clinical outcomes of endoscopic and endoscopic-assisted resection of inverted papillomas: a 15-year experience. Am J Rhinol. 2007;21(5):591-600.
Kaza S, Capasso R, Casiano RR. Endoscopic resection of inverted papilloma: University of Miami experience. Am J Rhinol. 2003;17(4):185-190.
Karligkiotis A, Lepera D, Volpi L, et al. Survival outcomes after endoscopic resection for sinonasal squamous cell carcinoma arising on inverted papilloma. Head Neck. 2016;38(11):1604-1614.
de Almeida JR, Su SY, Koutourousiou M, et al. Endonasal endoscopic surgery for squamous cell carcinoma of the sinonasal cavities and skull base: oncologic outcomes based on treatment strategy and tumor etiology. Head Neck. 2015;37(8):1163-1169.
Yasumatsu R, Nakashima T, Sato M, et al. Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma. Auris Nasus Larynx. 2017;44(1):98-103.
Yan CH, Newman JG, Kennedy DW, Palmer JN, Adappa ND. Clinical outcomes of sinonasal squamous cell carcinomas based on tumor etiology. Int Forum Allergy Rhinol. 2017;7(5):508-513.
Lobo BC, D'Anza B, Farlow JL, et al. Outcomes of sinonasal squamous cell carcinoma with and without association of inverted papilloma: a multi-institutional analysis. Am J Rhinol Allergy. 2017;31(5):305-309.
Li W, Lu H, Zhang H, Sun X, Hu L, Wang D. Squamous cell carcinoma associated with inverted papilloma: recurrence and prognostic factors. Oncol Lett. 2020;19(1):1082-1088.
Li Y, Wang C, Wang R, et al. Survival outcomes and prognostic factors of squamous cell carcinomas arising from sinonasal inverted papillomas: a retrospective analysis of 120 patients. Int Forum Allergy Rhinol. 2019;9(11):1367-1373.
Quan H, Zhang H, Zou L, Yuan W, Wang S. Comparison of outcomes between patients with de-novo sinonasal squamous cell carcinoma vs malignant transformations from inverted papillomas. Int Forum Allergy Rhinol. 2020;10(6):762-767.
Rutenberg M, Kirwan J, Morris CG, Werning JW, Mendenhall WM. Radiation therapy for sinonasal inverted papilloma. Pract Radiat Oncol. 2013;3(4):275-281.
Tanvetyanon T, Qin D, Padhya T, Kapoor R, McCaffrey J, Trotti A. Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis. Am J Otolaryngol. 2009;30(1):38-43.
Kim K, Kim D, Koo Y, et al. Sinonasal carcinoma associated with inverted papilloma: a report of 16 cases. J Craniomaxillofac Surg. 2012;40(4):e125-e129.
But-Hadzic J, Jenko K, Poljak M, Kocjan BJ, Gale N, Strojan P. Sinonasal inverted papilloma associated with squamous cell carcinoma. Radiol Oncol. 2011;45(4):267-272.
Li Y, Wang C, Wang R, et al. Prognostic factors of sinonasal squamous cell carcinomas arising de novo and from inverted papilloma. Am J Rhinol Allergy. 2021;35(1):114-121.
Yasumatsu R, Jiromaru R, Hongo T, et al. A clinical analysis of sinonasal squamous cell carcinoma: a comparison of de novo squamous cell carcinoma and squamous cell carcinoma arising from inverted papilloma. Acta Otolaryngol. 2020;140(8):698-703.
Gomez JA, Mendenhall WM, Tannehill SP, Stringer SP, Cassisi NJ. Radiation therapy in inverted papillomas of the nasal cavity and paranasal sinuses. Am J Otolaryngol. 2000;21(3):174-178.
Yu MS, Lim WS, Lee B-J, Chung Y-S. Squamous cell carcinoma associated with inverted papilloma of the maxillary sinus: our experience with 21 patients. Clin Otolaryngol. 2017;42(5):1048-1052.
Liang Q-Z, Li D-Z, Wang X-L, Huang H, Xu Z-G, Wu Y-H. Survival outcome of squamous cell carcinoma arising from sinonasal inverted papilloma. Chin Med J (Engl). 2015;128(18):2457-2461.
Shipchandler TZ, Batra PS, Citardi MJ, Bolger WE, Lanza DC. Outcomes for endoscopic resection of sinonasal squamous cell carcinoma. Laryngoscope. 2005;115(11):1983-1987.
Lee JJ, Peterson AM, Embry TW, et al. Survival outcomes of de novo vs inverted papilloma-associated sinonasal squamous cell carcinoma: a systematic review and meta-analysis. JAMA Otolaryngol Neck Surg [Internet]. 2021;147:350-359. doi:10.1001/jamaoto.2020.5261
Fornelli RA, Fedok FG, Wilson EP, Rodman SM. Squamous cell carcinoma of the anterior nasal cavity: a dual institution review. Otolaryngol Head Neck Surg. 2000;123(3):207-210.
Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34(6):877-885.
Tajudeen BA, Arshi A, Suh JD, et al. Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013. J Neurol Surg B Skull Base. 2015;76(1):43-49.
Ward PD, Heth JA, Thompson BG, Marentette LJ. Esthesioneuroblastoma: results and outcomes of a single institution's experience. Skull Base. 2009;19(2):133-140.
Husain Q, Kanumuri VV, Svider PF, et al. Sinonasal adenoid cystic carcinoma: systematic review of survival and treatment strategies. Otolaryngol Head Neck Surg. 2013;148(1):29-39.
Kokemueller H, Eckardt A, Brachvogel P, Hausamen J-E. Adenoid cystic carcinoma of the head and neck-a 20 years experience. Int J Oral Maxillofac Surg. 2004;33(1):25-31.
Kuan EC, Arshi A, Mallen-St Clair J, Tajudeen BA, Abemayor E, St John MA. Significance of tumor stage in sinonasal undifferentiated carcinoma survival: a population-based analysis. Otolaryngol Head Neck Surg. 2016;154(4):667-673.
Wang T, Huang Y, Lu J, Xiang M. Sinonasal mucosal melanoma: a 10-year experience of 36 cases in China. Ann Transl Med. 2020;8(16):1022.
Koivunen P, Bäck L, Pukkila M, et al. Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma. Laryngoscope. 2012;122(8):1734-1738.
Sahnane N, Ottini G, Turri-Zanoni M, et al. Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal-inverted papilloma to squamous cell carcinoma. Int J Cancer. 2019;144(6):1313-1320.
Udager AM, Rolland DCM, McHugh JB, et al. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res [Internet]. 2015;75(13):2600-2606. Accessed xxxx. https://pubmed.ncbi.nlm.nih.gov/25931286